Evidence question

PubMed sourcedAbstract-based analysisUpdated Sep 2026Human reviewedUpdated Aug 2026

Evidence / Thyroid

CoverageThyroid

What factors interfere with levothyroxine absorption?

Reviewed by Neal Rouzier, MD, Preventive Medicine · Aug 2026

Updated Aug 2026·11 studies analyzed·5 core studies·Applies to: older adults with subclinical hypothyroidism

Bottom line

Levothyroxine absorption is reduced by concurrent iron, calcium, PPIs, and some foods including coffee and fiber. Consistent fasting dosing separated from interfering substances improves TSH stability.[1–6]

Evidence confidence

Evidence Confidence

High
LimitedModerateHigh

Multiple high-quality studies directly address this question, with generally consistent findings.

Key uncertainty. Individual absorption variability and adherence patterns affect TSH stability beyond known interactions.

Ask RAGMD

Get the live evidence synthesis

10 complimentary queries. Full clinical intelligence — PubMed citations, conflict analysis, Evidence Confidence — with 7-day free trial.

Ask this questionStart free trialWhy physicians use RAGMD

Also asked

Levothyroxine coffee calcium▼

Levothyroxine absorption is reduced by concurrent iron, calcium, PPIs, and some foods including coffee and fiber. Consistent fasting dosing separated from interfering substances improves TSH stability.

T4 drug interactions▼

Levothyroxine absorption is reduced by concurrent iron, calcium, PPIs, and some foods including coffee and fiber. Consistent fasting dosing separated from interfering substances improves TSH stability.

Body of evidence

Clinical Evidence Brief

RAGMD analyzed 9 relevant studies.

Overall finding

6 studies address tsh / thyroid function, with weighted findings showing a positive association. 4 studies address hypothyroid symptoms / quality of life, with weighted findings showing a positive association. 3 studies address mood-related cognitive symptoms, with weighted findings showing no meaningful effect. 1 study addresses fertility / spermatogenesis, with weighted findings showing unclear findings. 4 randomized or systematic-review reports and 5 observational studies address treatment. Instruct consistent fasting levothyroxine dosing separated from iron, calcium, PPIs, sucralfate, and coffee by at least 30–60 minutes.

Evidence by outcome

Direction: ↑ Favors treatment / reassuring · ↓ Harm signal · ↔ No clear effect · ± Mixed · ↗ Observational link · ? Unclear

Positive link

TSH / thyroid function

high · 6 studies

6 studies address tsh / thyroid function, with weighted findings showing a positive association. This is an objectively measured outcome. This is a surrogate endpoint and does not by itself prove a hard clinical outcome.

Objectively measured · Surrogate endpoint

Studies

PMID 42438581PMID 28402245PMID 41938307PMID 41838451PMID 34093444PMID 41559017
Positive link

Hypothyroid symptoms / quality of life

high · 4 studies

4 studies address hypothyroid symptoms / quality of life, with weighted findings showing a positive association. This is a patient-reported / subjective outcome.

Patient-reported

Studies

PMID 28402245PMID 41938307PMID 41838451PMID 32365355
No clear effect

Mood-related cognitive symptoms

high · 3 studies

3 studies address mood-related cognitive symptoms, with weighted findings showing no meaningful effect. This is a patient-reported / subjective outcome.

Patient-reported

Studies

PMID 16868265PMID 41938307PMID 41559017
Unclear

Fertility / spermatogenesis

moderate · 1 study

1 study addresses fertility / spermatogenesis, with weighted findings showing unclear findings. This is an objectively measured outcome. This is a hard clinical endpoint.

Objectively measured · Hard clinical endpoint

Studies

PMID 41938307
Positive link

Quality of life

moderate · 1 study

1 study addresses quality of life, with weighted findings showing a positive association. This is a patient-reported / subjective outcome.

Patient-reported

Studies

PMID 41838451
No clear effect

Sleep-related cognitive symptoms

moderate · 1 study

1 study addresses sleep-related cognitive symptoms, with weighted findings showing no meaningful effect.

Mixed measurement

Studies

PMID 41559017

Magnitude / clinical importance

Validated effect estimates in the analyzed set include or 25; OR 5.0; RR = 15.54; HR 0.74. Statistical significance is not the same as clinical importance.

Where quantified, effects were often statistically detectable but small in absolute terms.

Agreement across studies

Most studies agree on hypothyroid symptoms / quality of life (a positive association), while tsh / thyroid function findings are a positive association and less consistent across domains.

Supports main conclusion: 3 · Neutral / mixed: 6 · Credible conflicting: 0

Study counts describe the landscape; RAGMD weights studies according to design, quality, and directness.

Conflicting findings

  • Refractory hypothyroidism despite high-dose levothyroxine therapy is most commonly attributed to poor adherence or gastrointestinal malabsorption; however, drug-drug interactions remain an important…
  • LT4 monotherapy is overwhelmingly employed as first line therapy for hypothyroidism by U.S.
  • MDD and GAD are overrepresented in NASH subjects and are associated with more advanced liver histological abnormalities.

Risks & harms

1 study reports safety-relevant findings. Design mix: Systematic review / meta-analysis. Rare-event inference should not rest on underpowered trials alone.

Who this applies to

Most studies included older adults with subclinical hypothyroidism.

What remains uncertain

  • Individual absorption variability and adherence patterns affect TSH stability beyond known interactions.
  • Individual absorption variability and adherence patterns affect TSH stability beyond known interactions.

Clinical takeaway

Instruct consistent fasting levothyroxine dosing separated from iron, calcium, PPIs, sucralfate, and coffee by at least 30–60 minutes. When TSH is unstable, review adherence, timing, and interfering medications before escalating dose. Switching formulation or using liquid levothyroxine may help selected patients with documented malabsorption.

Positive link

TSH / thyroid function?

A positive association

high[42438581 · 28402245 · 41938307 · 41838451 · 34093444 · 41559017]

Positive link

Hypothyroid symptoms / quality of life?

A positive association

high[28402245 · 41938307 · 41838451 · 32365355]

No clear effect

Mood-related cognitive symptoms?

No meaningful effect

high[16868265 · 41938307 · 41559017]

Unclear

Fertility / spermatogenesis?

Unclear findings

moderate[41938307]

Positive link

Quality of life?

A positive association

moderate[41838451]

No clear effect

Sleep-related cognitive symptoms?

No meaningful effect

moderate[41559017]

Unclear

Major adverse cardiovascular events?

Unclear findings

limited[34093444]

Unclear

Mortality?

Unclear findings

limited[34093444]

4 randomized or systematic-review reports and 5 observational studies address treatment. Weighted treatment findings show a positive association.

4 RCT / systematic review · 5 observational

Large randomized trials strongly influence the conclusion

5 landmark studies with randomized or systematic-review designs strongly inform this conclusion.

Supporting studies provide additional context

6 supporting studies add context beyond the core evidence base.

Regimen & duration

Observational and supporting studies provide context and do not outrank higher-appropriateness designs.

Long-term uncertainty

Evidence beyond long follow-up windows and in certain subgroups remains less complete.

9 analyzed studies

Strongest evidence

Cureus2026

Landmark studyPMID 42438581

Unmasking Refractory Hypothyroidism: Persistent Iron-Levothyroxine Interaction Despite Appropriate Dose Separation.

Refractory hypothyroidism despite high-dose levothyroxine therapy is most commonly attributed to poor adherence or gastrointestinal malabsorption; however, drug-drug interactions remain an important and frequently under-recognised cause. Oral iron is known to impair levothyroxine absorption through chelation, and current clinical guidance recommends dose separation to mitigate this effect.

Case series
Evidence
Relevance
Behavioural brain research2013

Landmark studyPMID 23428746

Knockout of c-Jun N-terminal kinases 1, 2 or 3 isoforms induces behavioural changes.

c-Jun N-terminal kinases (JNKs) are central and ubiquitous mediators of cellular signaling for both physiogical-regenerative and pathological-apoptotic processes. Their impact on degeneration or inflammation is well documented, but so far little is known about their roles in higher brain functions.

Study
Evidence
Relevance
Psychosomatic medicine2006

Landmark studyPMID 16868265

Depression, anxiety, and nonalcoholic steatohepatitis.

MDD and GAD are overrepresented in NASH subjects and are associated with more advanced liver histological abnormalities. Additional investigation will be required to determine if depression and anxiety affect the development or progression of NASH and serve as modifiable risk factors.

Study
Evidence
Relevance

1 additional landmark study linked to this question.

Supporting literature

Additional treatment strategies for hypothyroidism: a network meta-analysis.

Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled Trials.

L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized Trial.

+3 more

More in this focus area

Related evidence analyses

Other structured clinical questions in Thyroid.

Does combination T3/T4 therapy improve symptoms versus levothyroxine alone?

Randomized trials and meta-analyses show inconsistent symptom benefit from adding liothyronine to levothyroxine compared with levothyroxine monotherapy. Guidelines generally recommend levothyroxine as first-line therapy.

11 linked studies

Should subclinical hypothyroidism be treated with levothyroxine?

The TRUST trial found no meaningful symptom or quality-of-life benefit from levothyroxine in older adults with subclinical hypothyroidism. Treatment may still be considered with very high TSH, pregnancy plans, or specific clinical contexts.

11 linked studies

Is desiccated thyroid extract superior to levothyroxine for hypothyroidism?

Levothyroxine is standard first-line therapy with the strongest outcome evidence. Desiccated thyroid extract lacks modern RCT data demonstrating superiority and has variable hormone content between batches.

11 linked studies

What TSH target is appropriate for treated hypothyroidism?

Most guidelines suggest maintaining TSH within the reference range on levothyroxine, often near the lower half for many patients. Pregnancy and specific comorbidities require tighter targets.

11 linked studies

Go deeper on Thyroid

Full evidence synthesis, study comparisons, conflicting evidence, and expert commentary are available with RAGMD. Ask follow-up questions, explore related topics, and see how the evidence has evolved.

Ask RAGMDExplore ThyroidView pricing